Trials / Conditions / Schistosoma Haematobium

Schistosoma Haematobium

8 registered clinical trials studyying Schistosoma Haematobium — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Performance of Tests for Schistosoma Haematobium Diagnosis NCT06808750	Stefanie Knopp	—
Not Yet Recruiting	Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases. NCT05941884	Assiut University	—
Completed	Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children NCT03893097	Institute of Tropical Medicine, Belgium	Phase 3
Withdrawn	Leiden University Medical Center Mini Donor Bank NCT02810613	Leiden University Medical Center	—
Completed	Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma NCT01163877	Swiss Federal Institute of Technology	N/A
Completed	Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Hae NCT00870649	Institut National de la Santé Et de la Recherche Médicale, France	Phase 3
Completed	Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis NCT00510159	Dafra Pharma	Phase 2 / Phase 3
Completed	Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar NCT00713999	University of Aarhus	N/A